Statistics

Total Visits

Views
Docetaxel in combination with Temsirolimus in patients with advanced castration resistant prostate cancer (CRPC): A phase II trial of the Spanish Oncology Genitourinary Group77

Select a period of time:

Number of views in the range

Views
Docetaxel in combination with Temsirolimus in patients with advanced castration resistant prostate cancer (CRPC): A phase II trial of the Spanish Oncology Genitourinary Group13

Views

Views
September 20253
October 20251
November 20255
December 20250
January 20263
February 20261
March 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States3
Brazil3
Mexico2
Argentina2
Colombia1
Paraguay1
Singapore1
 

Top cities views

Views
Dallas2
Asunción1
Lomas de Zamora1
Luziânia1
Monterrey1
Praia Grande1
Resistencia1
Santiago de Cali1
Tecámac1
Uruburetama1